Thermopylae Holdings Ltd. bought ABCL
February 26, 2026 · Form 4 insider transaction
Thermopylae Holdings Ltd. bought 177,457 shares of AbCellera Biologics Inc. at $3.27 per share, a transaction worth $580.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
177,457
Price
$3.27
Total value
$580.3K
InsiderThermopylae Holdings Ltd.
Role—
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateFebruary 26, 2026
Filing dateFebruary 27, 2026
Shares owned after56,096,097
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $3.19 to $3.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.